Michael Kagnoff, Director at GenMark Diagnostics, Inc. (GNMK), bought 10,000 shares at $4.22 ($42K) on 2018-03-01, disclosed to the SEC on 2018-03-05.
Open-market purchase of $42k GNMK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| GNMK | BUY | 2017-09-11 | $23K | — | Filing → |
| GNMK | BUY | 2016-11-22 | $24K | — | Filing → |
| GNMK | BUY | 2016-11-14 | $25K | — | Filing → |